Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZS89
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,834
Award facts
- Contract value 100% obligated
- $99,834.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $99,834.40 by the Defense Logistics Agency (DLA) for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 25, 2025, with an ultimate completion date of October 17, 2025, carries no set-aside designation. EXPAREL is a liposomal bupivacaine formulation used for infiltration and nerve block anesthesia in surgical settings, representing a specialized pharmaceutical product within the company's broader medical supply portfolio.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while providing direct distribution of prescription drugs and medical consumables to military health systems.
Quick answers
Who was awarded contract SPE2DB25FZS89?
SPE2DB25FZS89 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FZS89 worth?
The government has obligated $99,834 on SPE2DB25FZS89.
Is contract SPE2DB25FZS89 an order under another contract?
Yes. SPE2DB25FZS89 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS89 competed?
The extent of competition for SPE2DB25FZS89 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award